141 related articles for article (PubMed ID: 10777570)
1. Successful targeting to rat hepatic stellate cells using albumin modified with cyclic peptides that recognize the collagen type VI receptor.
Beljaars L; Molema G; Schuppan D; Geerts A; De Bleser PJ; Weert B; Meijer DK; Poelstra K
J Biol Chem; 2000 Apr; 275(17):12743-51. PubMed ID: 10777570
[TBL] [Abstract][Full Text] [Related]
2. Disease-induced drug targeting using novel peptide-ligand albumins.
Meijer DK; Beljaars L; Molema G; Poelstra K
J Control Release; 2001 May; 72(1-3):157-64. PubMed ID: 11389994
[TBL] [Abstract][Full Text] [Related]
3. Albumin modified with mannose 6-phosphate: A potential carrier for selective delivery of antifibrotic drugs to rat and human hepatic stellate cells.
Beljaars L; Molema G; Weert B; Bonnema H; Olinga P; Groothuis GM; Meijer DK; Poelstra K
Hepatology; 1999 May; 29(5):1486-93. PubMed ID: 10216133
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of the hepatic stellate cell-selective carrier mannose 6-phosphate modified albumin (M6P(28)-HSA).
Beljaars L; Olinga P; Molema G; de Bleser P; Geerts A; Groothuis GM; Meijer DK; Poelstra K
Liver; 2001 Oct; 21(5):320-8. PubMed ID: 11589768
[TBL] [Abstract][Full Text] [Related]
5. Peptide-modified albumin carrier explored as a novel strategy for a cell-specific delivery of interferon gamma to treat liver fibrosis.
Bansal R; Prakash J; de Ruijter M; Beljaars L; Poelstra K
Mol Pharm; 2011 Oct; 8(5):1899-909. PubMed ID: 21800888
[TBL] [Abstract][Full Text] [Related]
6. Effects of a new bioactive lipid-based drug carrier on cultured hepatic stellate cells and liver fibrosis in bile duct-ligated rats.
Adrian JE; Poelstra K; Scherphof GL; Meijer DK; van Loenen-Weemaes AM; Reker-Smit C; Morselt HW; Zwiers P; Kamps JA
J Pharmacol Exp Ther; 2007 May; 321(2):536-43. PubMed ID: 17314198
[TBL] [Abstract][Full Text] [Related]
7. A novel lipid-based drug carrier targeted to the non-parenchymal cells, including hepatic stellate cells, in the fibrotic livers of bile duct ligated rats.
Adrian JE; Kamps JA; Scherphof GL; Meijer DK; van Loenen-Weemaes AM; Reker-Smit C; Terpstra P; Poelstra K
Biochim Biophys Acta; 2007 Jun; 1768(6):1430-9. PubMed ID: 17493581
[TBL] [Abstract][Full Text] [Related]
8. Targeting 15d-prostaglandin J2 to hepatic stellate cells: two options evaluated.
Hagens WI; Mattos A; Greupink R; de Jager-Krikken A; Reker-Smit C; van Loenen-Weemaes A; Gouw IA; Poelstra K; Beljaars L
Pharm Res; 2007 Mar; 24(3):566-74. PubMed ID: 17245650
[TBL] [Abstract][Full Text] [Related]
9. The antiproliferative drug doxorubicin inhibits liver fibrosis in bile duct-ligated rats and can be selectively delivered to hepatic stellate cells in vivo.
Greupink R; Bakker HI; Bouma W; Reker-Smit C; Meijer DK; Beljaars L; Poelstra K
J Pharmacol Exp Ther; 2006 May; 317(2):514-21. PubMed ID: 16439617
[TBL] [Abstract][Full Text] [Related]
10. Local inhibition of liver fibrosis by specific delivery of a platelet-derived growth factor kinase inhibitor to hepatic stellate cells.
Gonzalo T; Beljaars L; van de Bovenkamp M; Temming K; van Loenen AM; Reker-Smit C; Meijer DK; Lacombe M; Opdam F; Kéri G; Orfi L; Poelstra K; Kok RJ
J Pharmacol Exp Ther; 2007 Jun; 321(3):856-65. PubMed ID: 17369283
[TBL] [Abstract][Full Text] [Related]
11. Hepatic stellate cell-targeted delivery of M6P-HSA-glycyrrhetinic acid attenuates hepatic fibrogenesis in a bile duct ligation rat model.
Luk JM; Zhang QS; Lee NP; Wo JY; Leung PP; Liu LX; Hu MY; Cheung KF; Hui CK; Lau GK; Fan ST
Liver Int; 2007 May; 27(4):548-57. PubMed ID: 17403195
[TBL] [Abstract][Full Text] [Related]
12. Targeting of sugar- and charge-modified albumins to fibrotic rat livers: the accessibility of hepatic cells after chronic bile duct ligation.
Beljaars L; Poelstra K; Molema G; Meijer DK
J Hepatol; 1998 Oct; 29(4):579-88. PubMed ID: 9824267
[TBL] [Abstract][Full Text] [Related]
13. Interaction of targeted liposomes with primary cultured hepatic stellate cells: Involvement of multiple receptor systems.
Adrian JE; Poelstra K; Scherphof GL; Molema G; Meijer DK; Reker-Smit C; Morselt HW; Kamps JA
J Hepatol; 2006 Mar; 44(3):560-7. PubMed ID: 16368158
[TBL] [Abstract][Full Text] [Related]
14. K⁺-channel inhibition reduces portal perfusion pressure in fibrotic rats and fibrosis associated characteristics of hepatic stellate cells.
Freise C; Heldwein S; Erben U; Hoyer J; Köhler R; Jöhrens K; Patsenker E; Ruehl M; Seehofer D; Stickel F; Somasundaram R
Liver Int; 2015 Apr; 35(4):1244-52. PubMed ID: 25212242
[TBL] [Abstract][Full Text] [Related]
15. Reduction of fibrogenesis by selective delivery of a Rho kinase inhibitor to hepatic stellate cells in mice.
van Beuge MM; Prakash J; Lacombe M; Gosens R; Post E; Reker-Smit C; Beljaars L; Poelstra K
J Pharmacol Exp Ther; 2011 Jun; 337(3):628-35. PubMed ID: 21383021
[TBL] [Abstract][Full Text] [Related]
16. The preferential homing of a platelet derived growth factor receptor-recognizing macromolecule to fibroblast-like cells in fibrotic tissue.
Beljaars L; Weert B; Geerts A; Meijer DK; Poelstra K
Biochem Pharmacol; 2003 Oct; 66(7):1307-17. PubMed ID: 14505810
[TBL] [Abstract][Full Text] [Related]
17. Studies on the targeted delivery of the antifibrogenic compound mycophenolic acid to the hepatic stellate cell.
Greupink R; Bakker HI; Reker-Smit C; van Loenen-Weemaes AM; Kok RJ; Meijer DK; Beljaars L; Poelstra K
J Hepatol; 2005 Nov; 43(5):884-92. PubMed ID: 16083988
[TBL] [Abstract][Full Text] [Related]
18. Delivery of viral vectors to hepatic stellate cells in fibrotic livers using HVJ envelopes fused with targeted liposomes.
Adrian JE; Kamps JA; Poelstra K; Scherphof GL; Meijer DK; Kaneda Y
J Drug Target; 2007 Jan; 15(1):75-82. PubMed ID: 17365276
[TBL] [Abstract][Full Text] [Related]
19. Rho-kinase inhibitor coupled to peptide-modified albumin carrier reduces portal pressure and increases renal perfusion in cirrhotic rats.
Klein S; Frohn F; Magdaleno F; Reker-Smit C; Schierwagen R; Schierwagen I; Uschner FE; van Dijk F; Fürst DO; Djudjaj S; Boor P; Poelstra K; Beljaars L; Trebicka J
Sci Rep; 2019 Feb; 9(1):2256. PubMed ID: 30783172
[TBL] [Abstract][Full Text] [Related]
20. Icaritin induces cell death in activated hepatic stellate cells through mitochondrial activated apoptosis and ameliorates the development of liver fibrosis in rats.
Li J; Liu P; Zhang R; Cao L; Qian H; Liao J; Xu W; Wu M; Yin Z
J Ethnopharmacol; 2011 Sep; 137(1):714-23. PubMed ID: 21726622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
